Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88371925 |
LAW OFFICE ASSIGNED |
LAW OFFICE 108 |
MARK SECTION |
MARK |
SEBELA PHARMACEUTICALS (see, http://uspto.report/TM/88371925/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
SEBELA PHARMACEUTICALS |
OWNER SECTION (current) |
NAME |
SEBELA IRELAND LIMITED |
INTERNAL ADDRESS |
3RD FLOOR, WEST WING, ADELAIDE CHAMBERS, |
STREET |
PETER STREET |
CITY |
DUBLIN |
ZIP/POSTAL CODE |
8 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Ireland |
OWNER SECTION (proposed) |
NAME |
SEBELA IRELAND LIMITED |
INTERNAL ADDRESS |
3RD FLOOR, WEST WING, ADELAIDE CHAMBERS, |
STREET |
PETER STREET |
CITY |
DUBLIN |
ZIP/POSTAL CODE |
8 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Ireland |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
Jeffrey H. Handelsman |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
GREENBLUM & BERNSTEIN, P.L.C. |
STREET |
1950 ROLAND CLARKE PLACE |
CITY |
RESTON |
STATE |
Virginia |
POSTAL CODE |
20191-1411 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
703-716-1191 |
FAX |
703-716-1180 |
EMAIL |
eteas@gbpatent.com |
DOCKET/REFERENCE NUMBER |
T57551 |
ATTORNEY INFORMATION (proposed) |
NAME |
Jeffrey H. Handelsman |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
GREENBLUM & BERNSTEIN, P.L.C. |
STREET |
1950 ROLAND CLARKE PLACE |
CITY |
RESTON |
STATE |
Virginia |
POSTAL CODE |
20191-1411 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
703-716-1191 |
FAX |
703-716-1180 |
EMAIL |
eteas@gbpatent.com |
DOCKET/REFERENCE NUMBER |
T57551 |
OTHER APPOINTED ATTORNEY |
Neil F. Greenblum; Bruce H. Bernstein; William S. Boshnick; Jill M. Browning |
CORRESPONDENCE INFORMATION (current) |
NAME |
JEFFREY H. HANDELSMAN |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
eteas@gbpatent.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Jeffrey H. Handelsman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
eteas@gbpatent.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
T57551 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical and medicated preparations for use in nephrology, neurology, oncology, urology, andrology and cardiology, and for use in the
treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for
the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and
prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; all of the aforesaid goods not
for use as a product name of a pharmaceutical product |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
10/15/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Jeffrey H. Handelsman/ |
SIGNATORY'S NAME |
Jeffrey H. Handelsman |
SIGNATORY'S POSITION |
Attorney for Applicant, MD Bar (Ref.: T57551) |
DATE SIGNED |
04/15/2020 |
SIGNATORY'S PHONE NUMBER |
703-716-1191 |
FILING INFORMATION |
SUBMIT DATE |
Wed Apr 15 11:06:44 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XXX.XXX
-20200415110644897456-883
71925-7103e2e837351d33a72
fba44ae07b12ccdaec4c7f844
c39a969bc741aafb68234c7-C
C-06430028-20200415105210
844078 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: SEBELA PHARMACEUTICALS (see, http://uspto.report/TM/88371925/mark.png)
SERIAL NUMBER: 88371925
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: SEBELA IRELAND LIMITED, having an address of
3RD FLOOR, WEST WING, ADELAIDE CHAMBERS,
PETER STREET
DUBLIN, 8
Ireland
Proposed: SEBELA IRELAND LIMITED, having an address of BB
3RD FLOOR, WEST WING, ADELAIDE CHAMBERS,
PETER STREET
DUBLIN, 8
Ireland
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 10/15/2019.
For International Class 005:
Current identification: Pharmaceutical and medicated preparations for use in nephrology, neurology, oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies,
respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases;
preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female
sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and candidiasis; all of the aforesaid goods not for use as a product name of a
pharmaceutical product
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
The applicant's current Attorney Information:
Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.
1950 ROLAND CLARKE PLACE
RESTON, Virginia 20191-1411
United States
Phone: 703-716-1191
Fax: 703-716-1180
The docket/reference number is T57551
Email: eteas@gbpatent.com
The applicant's proposed Attorney Information:
Jeffrey H. Handelsman GREENBLUM & BERNSTEIN, P.L.C.
1950 ROLAND CLARKE PLACE
RESTON, Virginia 20191-1411
United States
Phone: 703-716-1191
Fax: 703-716-1180
The docket/reference number is T57551
Email: eteas@gbpatent.com
Correspondence Information (current):
JEFFREY H. HANDELSMAN
PRIMARY EMAIL FOR CORRESPONDENCE: eteas@gbpatent.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Jeffrey H. Handelsman
PRIMARY EMAIL FOR CORRESPONDENCE: eteas@gbpatent.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Jeffrey H. Handelsman/ Date Signed: 04/15/2020
Signatory's Name: Jeffrey H. Handelsman
Signatory's Position: Attorney for Applicant, MD Bar (Ref.: T57551)
Signatory's Phone: 703-716-1191
Mailing Address:
GREENBLUM & BERNSTEIN, P.L.C.
1950 ROLAND CLARKE PLACE
RESTON, Virginia 20191-1411
RAM Sale Number: 88371925
RAM Accounting Date: 04/15/2020
Serial Number: 88371925
Internet Transmission Date: Wed Apr 15 11:06:44 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20200415110644
897456-88371925-7103e2e837351d33a72fba44
ae07b12ccdaec4c7f844c39a969bc741aafb6823
4c7-CC-06430028-20200415105210844078